News
Sobi launches thrombocytopenia drug Doptelet in EU
Sobi (Swedish Orphan Biovitrum) has launched Doptelet (avatrombopag) in Europe, which is approved for the treatment of severe thrombocytopenia in adult patients with chronic liver disease (CLD).